Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-13

Clinical Trial Update: Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of oral rivaroxaban for cerebral venous thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xarelto (rivaroxaban)

Snippet

Sponsor: Muhammad Aamir Latif | Conditions: Cerebrosinovenous Thrombosis | NA | Status: COMPLETED